ZachariahDefilippMD

PubMed

• A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.
  Kapoor, U., Muna Qayed, Urvi Kapoor, Scott Gillespie, Adrianna Westbrook, Paibel Aguayo-Hiraldo, Francis A Ayuk, Mina Aziz, Janna Baez, Hannah Choe, Zachariah DeFilipp...> ;Transplantation and Cellular Therapy. 2024 Mar 27
• Vitamin A keeps the GVHD away?
  Zachariah DeFilipp> ;Blood. 2024 Mar 21
• Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.
  Zachariah DeFilipp, Ashish V Damania, Haesook T Kim, Chang Chia-Chi, Areej El-Jawahri, Steven L McAfee, Aj S Bottoms, Vesselina Toncheva, Melissa M Smith, Maria Dolahe...> ;Blood Advances. 2024 Mar 12
• Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis.
  Al Malki, M. M., Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting Dr. med, Paibel Aguayo-Hiraldo, Francis Ayuketang Ayuk, Chantiya Chanswangphuwana, Hannah K Choe, Matt...> ;Blood Advances. 2024 Feb 7
• A Day 14 Endpoint for Acute GVHD Clinical Trials.
  Al Malki, M. M., Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo-Hiraldo, Monzr M Al Malki, Francis Ayuk, Peter Bader, Ja...> ;Transplantation and Cellular Therapy. 2024 Feb 4
• Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial.
  Ashley M Nelson, Daniel Yang, Annemarie D Jagielo, Jennifer D'Alotto, Cathleen Poliquin, Dustin J Rabideau, Katherine G Cronin, Richard A Newcomb, Yi-Bin Chen, Zachari...> ;Journal of the National Comprehensive Cancer Network. 2024 Feb 1
• AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients.
  Kim, H., Ali, R., Short, S., Kaunfer, S., Krishnamurthy, S., Durai, L., Yilmam, O., Shenoy, T., Monson, A., Thomas, C., Park, I., Martini, D., Newcomb, R., Shapiro, R....> ;Bone Marrow Transplantation. 2024 Feb 1
• Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation.
  Yang, D., Newcomb, R., Kavanaugh, A., Khalil, D., Greer, J., LeBlanc, T., Chen, Y., DeFilipp, Z., Temel, J., Lee, S., El-Jawahri, A.> ;Contemporary Clinical Trials. 2024 Mar 1
• 1 citations
  Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.
  Catherine J Lee, Tao Wang, Karen Chen, Mukta Arora, Ruta Brazauskas, Stephen R Spellman, Carrie Kitko, Margaret L MacMillan, Joseph A Pidala, Sherif M Badawy, Neel Bha...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide.
  Daniel J Ikeda, Zachariah DeFilipp, Kerry Collier, Yi-Bin Chen, Bimalangshu R Dey, Areej El-Jawahri, Matthew J Frigault, Mark B Leick, Steven L McAfee, Richard A Newco...> ;Bone Marrow Transplantation. 2024 Jan 1
• 1 citations
  Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD.
  Bidish K Patel, Michael J Raabe, Evan R Lang, Yuhui Song, Chenyue Lu, Vikram Deshpande, Linda T Nieman, Martin J Aryee, Yi-Bin Chen, David T Ting, Zachariah DeFilipp> ;Blood. 2023 Nov 23
• 1 citations
  Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation.
  Felix Korell, Zachariah DeFilipp, Nicholas Schreck, Thomas Luft> ;Intensive Care Medicine. 2023 Nov 1
• 11 citations
  Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy.
  Abraham S Kanate, Navneet Majhail, Zachariah DeFilipp, Binod Dhakal, Bhagirathbhai Dholaria, Betty Hamilton, Alex F Herrera, Yoshihiro Inamoto, Tania Jain, Miguel-Ange...> ;Transplantation and Cellular Therapy. 2023 Oct 1
• 2 citations
  A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
  Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, Mikaela M McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F Herrera, David C Fisher, Ann S LaCasce, Oreofe O Odeji...> ;Blood. 2023 Aug 17
• 1 citations
  Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.
  Yu Akahoshi, Nikolaos Spyrou, William J Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber, Hannah K Choe, Elizabeth O Hexner, Wolf Rösler, Aaron M Etra, Karamjeet...> ;Blood Advances. 2023 Aug 22
• The Frailty Factor: Quantifying a Familiar Foe in Chronic GVHD.
  Zachariah DeFilipp> ;Transplantation and Cellular Therapy. 2023 Jun 1
• 1 citations
  Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics.
  Ashley N Gray, Zachariah DeFilipp> ;Transplantation and Cellular Therapy. 2023 Aug 1
• 1 citations
  The utility of biomarkers in acute GVHD prognostication.
  Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra, William J Hogan, Wolf Rösler, Elizabeth Hexner, Zachariah DeFilipp, Ran Reshef, Chan...> ;Blood Advances. 2023 Sep 12
• 2 citations
  A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
  Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Hernández-Boluda, Sergio Giralt, Jeanne Palmer, Robert Peter Gale, Zachariah DeFilipp, Da...> ;Blood Advances. 2023 Aug 8
• How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?
  Mark Juckett, Christopher Dandoy, Zachariah DeFilipp, Tamila L Kindwall-Keller, Stephen R Spellman, Celalettin Ustun, Bryce M Waldman, Daniel J Weisdorf, William A Woo...> ;Blood Reviews. 2023 Jul 1
• 4 citations
  Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.
  Amir T Fathi, Haesook T Kim, Robert J Soiffer, Mark J Levis, Shuli Li, Annette S Kim, Zachariah DeFilipp, Areej El-Jawahri, Steve L McAfee, Andrew M Brunner, Philip C ...> ;Clinical Cancer Research. 2023 Jun 1
• 1 citations
  Linking the microbiome to CAR-T cell responses.
  Zachariah DeFilipp, Marcela V Maus> ;Nature Medicine. 2023 Apr 1
• 4 citations
  Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell Transplantation.
  Richard Newcomb, P Connor Johnson, Katherine Cronin, Joanna J Choe, Katherine Holmbeck, Anisa Nabily, Porsha Lark, Dustin J Rabideau, Zachariah DeFilipp, Yi-Bin Chen, ...> ;Transplantation and Cellular Therapy. 2023 Jun 1
• 9 citations
  Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
  Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal, Talha Badar, Sherif M Badawy, Karen Ballen, Amer Beitin...> ;Haematologica. 2023 Jul 1
• 9 citations
  Effective treatment of low-risk acute GVHD with itacitinib monotherapy.
  Kapoor, U., Aaron Etra, Alexandra Capellini, Amin Alousi, Monzr M Al Malki, Hannah Choe, Zachariah DeFilipp, William J Hogan, Carrie L Kitko, Francis Ayuk, Janna Baez,...> ;Blood. 2023 Feb 2
• Join now to see all

Journal Articles

• Indoles Derived from Intestinal Microbiota Act via Type I Interferon Signaling to Limit Graft-Versus-Host-Disease  
  Edmund K Waller, Zachariah DeFilipp, Muna Qayed, Akshay Sharma, Blood

Abstracts/Posters

• The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
  Zachariah Defilipp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Post-Transplant Cyclophosphamide in Allogeneic Bone Marrow Transplantation for the Treatment of Benign Hematologic Diseases
  Zachariah Defilipp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T Cells
  Zachariah Defilipp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019